Skip to Content
  • Previous Rank
  • Revenues ($M)
  • Revenue Percent Change
  • Profits ($M)
  • Profits Percent Change
  • Assets ($M)
  • Employees

AmerisourceBergen is the second-largest distributor of pharmaceuticals in the U.S. As such, it’s subject to many of the same forces affecting McKesson, its top competitor. Generic drug price deflation and fewer expected generic-drug launches will put pressure on overall industry profits this year and next. AmerisourceBergen has been working to counter those effects by entering new markets through strategic acquisitions. This includes getting into animal health distribution with MWI Veterinary Supply, compounding with PharMEDium, and clinical trial logistics with World Courier. AmerisourceBergen also could face a windfall of new revenue in coming years after its partner Walgreens absorbs Rite Aid and its more than 4,500 pharmacists.

Company Information

Figures are for fiscal year ended Sept. 30, 2015.
Steven H. Collis
Wholesalers: Health Care
HQ Location
Chesterbrook, PA
Years on Global 500 List17
Created with sketchtool.Created with sketchtool.Looking for leads, investment insights, or competitive intelligence?Purchase Now

AmerisourceBergen Rank History


Key Financials (last fiscal year)

($ Millions)% change
Revenues ($M)$135,96213.7%
Profits ($M)$-135-148.8%
Assets ($M)$27,736-
Total Stockholder Equity ($M)$634-

Profit Ratios

Profit as % of Revenues-0.1%
Profits as % of Assets-0.5%
Profits as % of Stockholder Equity-21.3%